Lennart Åkerblom

1.8k total citations
42 papers, 1.5k citations indexed

About

Lennart Åkerblom is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Lennart Åkerblom has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 21 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Lennart Åkerblom's work include HIV Research and Treatment (24 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Lennart Åkerblom is often cited by papers focused on HIV Research and Treatment (24 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Lennart Åkerblom collaborates with scholars based in Sweden, Netherlands and United Kingdom. Lennart Åkerblom's co-authors include Brør Morein, Jonathan L. Heeney, Peter Reichard, Sigvard Olofsson, Britta Wahrén, Erling Norrby, Anders Bolmstedt, Sigrid Sjölander, Jorma Hinkula and A Ehrenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lennart Åkerblom

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lennart Åkerblom Sweden 21 820 670 527 397 316 42 1.5k
Clotilde Thiriart Belgium 18 1.2k 1.4× 660 1.0× 645 1.2× 556 1.4× 567 1.8× 23 2.0k
D Schmitt France 20 681 0.8× 413 0.6× 487 0.9× 394 1.0× 325 1.0× 55 1.5k
Omar K. Haffar United States 21 754 0.9× 487 0.7× 560 1.1× 223 0.6× 388 1.2× 34 1.4k
Valerie Bosch Germany 20 883 1.1× 416 0.6× 611 1.2× 452 1.1× 586 1.9× 44 1.7k
D L Lynn United States 7 902 1.1× 434 0.6× 315 0.6× 227 0.6× 396 1.3× 8 1.1k
D P Bolognesi United States 20 1.4k 1.8× 925 1.4× 629 1.2× 474 1.2× 662 2.1× 39 2.1k
Catarina E. Hioe United States 27 1.1k 1.4× 1.1k 1.7× 532 1.0× 416 1.0× 479 1.5× 82 1.9k
Valérie Pasquetto United States 22 488 0.6× 1.1k 1.6× 827 1.6× 739 1.9× 298 0.9× 26 2.0k
C. Yong Kang Canada 23 425 0.5× 334 0.5× 464 0.9× 517 1.3× 460 1.5× 48 1.4k
Vaniambadi S. Kalyanaraman United States 29 1.7k 2.0× 1.3k 2.0× 456 0.9× 531 1.3× 573 1.8× 66 2.3k

Countries citing papers authored by Lennart Åkerblom

Since Specialization
Citations

This map shows the geographic impact of Lennart Åkerblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lennart Åkerblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lennart Åkerblom more than expected).

Fields of papers citing papers by Lennart Åkerblom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lennart Åkerblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lennart Åkerblom. The network helps show where Lennart Åkerblom may publish in the future.

Co-authorship network of co-authors of Lennart Åkerblom

This figure shows the co-authorship network connecting the top 25 collaborators of Lennart Åkerblom. A scholar is included among the top collaborators of Lennart Åkerblom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lennart Åkerblom. Lennart Åkerblom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, David A., Betty Willems, Karin Lövgren‐Bengtsson, et al.. (2003). Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120. Vaccine. 22(5-6). 747–754. 5 indexed citations
2.
Reid, Scott M., et al.. (2001). Development of a rapid chromatographic strip test for the pen-side detection of foot-and-mouth disease virus antigen. Journal of Virological Methods. 96(2). 189–202. 55 indexed citations
3.
Åkerblom, Lennart, Jan Albert, Torsten Unge, et al.. (2000). Monoclonal Antibodies to Native HIV Type 1 Reverse Transcriptase and Their Interaction with Enzymes from Different Subtypes. AIDS Research and Human Retroviruses. 16(13). 1281–1294. 8 indexed citations
4.
Cafaro, Aurelio, Antonella Caputo, C Fracasso, et al.. (1999). Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nature Medicine. 5(6). 643–650. 227 indexed citations
5.
Heeney, Jonathan L., Peter van der Meide, Carlo De Giuli Morghen, et al.. (1998). The role of type‐1 and type‐2 T‐helper immune responses in HIV‐1 vaccine protection. Journal of Medical Primatology. 27(2-3). 50–58. 16 indexed citations
6.
7.
Morris, T.J., et al.. (1997). Presentation of a foreign peptide on the surface of tomato bushy stunt virus.. Journal of General Virology. 78(6). 1213–1217. 75 indexed citations
8.
Bolmstedt, Anders, et al.. (1996). Influence of N-Linked Glycans in V4-V5 Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp160 on Induction of a Virus-Neutralizing Humoral Response. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(3). 213–220. 73 indexed citations
9.
10.
Sjölander, Sigrid, John‐Erik Stig Hansen, Karin Lövgren‐Bengtsson, Lennart Åkerblom, & Brør Morein. (1996). Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. Vaccine. 14(4). 344–352. 23 indexed citations
11.
Osterhaus, Albert D. M. E., Petra de Vries, Brør Morein, Lennart Åkerblom, & Jonathan L. Heeney. (1992). Comparison of Protection Afforded by Whole Virus ISCOM Versus MDP Adjuvanted Formalin-Inactivated SIV Vaccines from IV Cell-Free or Cell-Associated Homologous Challenge. AIDS Research and Human Retroviruses. 8(8). 1507–1510. 17 indexed citations
12.
Lövgren, Karin, et al.. (1992). Antigen‐Specific Increases in the Number of Splenocytes Expressing MHC Class II Molecules Following Restimulation with Antigen in Various Physical Forms. Scandinavian Journal of Immunology. 36(4). 565–574. 23 indexed citations
13.
Bolmstedt, Anders, Sigvard Olofsson, Eva Sjögren‐Jansson, et al.. (1992). Carbohydrate determinant NeuAc-Galbeta(1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. Journal of General Virology. 73(12). 3099–3105. 46 indexed citations
14.
Putkonen, Per, Rigmor Thorstensson, Lilian Walther–Jallow, et al.. (1991). Vaccine Protection Against HIV-2 Infection in Cynomolgus Monkeys. AIDS Research and Human Retroviruses. 7(3). 271–277. 57 indexed citations
15.
Åkerblom, Lennart, Peter L. Nara, Nancy M. Dunlop, & Brør Morein. (1991). Cross-Neutralizing Antibodies to HIV-1 in Mice After Immunization with gp160 Iscoms. Dissection of the Immune Response. AIDS Research and Human Retroviruses. 7(7). 621–627. 11 indexed citations
16.
Broliden, P A, Barbro Mäkitalo, Lennart Åkerblom, et al.. (1991). Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.. PubMed. 73(4). 371–6. 22 indexed citations
17.
Höglund, Stefan, Lennart Åkerblom, Muhsin Özel, et al.. (1990). Characterization of Immunostimulating Complexes (ISCOMS) of HIV-1. Viral Immunology. 3(3). 195–206. 9 indexed citations
18.
Broliden, P A, K Ljunggren, Jorma Hinkula, et al.. (1990). A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization. Journal of Virology. 64(2). 936–940. 54 indexed citations
19.
Kenne, Kerstin & Lennart Åkerblom. (1990). Deoxyribonucleoside triphosphate pool levels in three cell strains of human chromosome instability syndromes: ataxia telangiectasia (GM2052), Bloom's syndrome (GM1492), and Fanconi's anemia (GM368).. PubMed. 11(1). 69–77. 1 indexed citations
20.
Åkerblom, Lennart, et al.. (1989). Free gp70 from FeLV: Enrichment from Cell Culture Fluid by Ferric Oxide‐Agarose Chromatography. Biotechnology and Applied Biochemistry. 11(2). 209–216. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clotilde Thiriart Breakdown of academic impact, for papers by D Schmitt Breakdown of academic impact, for papers by Omar K. Haffar Breakdown of academic impact, for papers by Valerie Bosch Breakdown of academic impact, for papers by D L Lynn Breakdown of academic impact, for papers by D P Bolognesi Breakdown of academic impact, for papers by Catarina E. Hioe Breakdown of academic impact, for papers by Valérie Pasquetto Breakdown of academic impact, for papers by C. Yong Kang Breakdown of academic impact, for papers by Vaniambadi S. Kalyanaraman
Rankless by CCL
2026